The U.S. dollar extended its recent weakness on Wednesday, as risk sentiment improved after Gilead Sciences claimed that the results of its study showed improvement in patients taking its remdesivir to treat the coronavirus infection.
The National Institute of Allergy and Infectious Diseases has said that a study of Gilead's remdesivir drug met its primary endpoint, lifting expectations for a potential coronavirus treatment.
For comments and feedback contact: editorial@rttnews.com
Forex News
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.